Sila Realty Trust, Inc.

Listed Company

SILACIK 0001567925NYSELarge AcceleratedReal Estate Investment TrustsMarylandFY ends Dec 31

Period

FY 2025

Revenue

$197.54M

Net Income

$33.12M

Total Assets

—

Equity

—

Shares Out

55.24M

Op. Cash Flow

$119.14M

Business

Sila Realty Trust, Inc. is a REIT that invests primarily in high‑quality healthcare facilities across the continuum of care. It acquires, owns and leases inpatient and outpatient healthcare properties, originates and acquires real‑estate related loans and mezzanine financing, and invests in non‑majority real estate securities. Substantially all operations are conducted through its consolidated Operating Partnership and the company is internally managed, pursuing acquisitions, joint ventures, and various financing and disposition strategies. Its properties and investments are predominantly located throughout the continental United States and leased to national, regional and local healthcare tenants.

Summary from filing dated 2025-03-03

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Rental revenue	196	187	189	180	—
Real estate related notes receivable interest income	1	0	0	—	—
Total revenues	198	187	189	180	173
Rental expenses	24	23	20	18	18
Listing-related expenses	0	3	0	0	—
General and administrative expenses	21	25	24	22	21
Depreciation and amortization	77	75	74	77	70
Impairment and disposition losses	10	1	24	47	—
Demolition costs	1	0	0	—	—
Total operating expenses	133	127	143	165	137
Gain on dispositions of real estate	0	341,000	22,000	460,000	89,000
Interest and other income	1	4	702,000	305,000	3
Interest expense	−33	−21	−23	−24	—
Increase in current expected credit loss reserve	−180,000	0	0	—	—
Total other expense	−32	−17	−22	−23	—
Net income attributable to common stockholders	33	43	24	−8	403
Other comprehensive loss - unrealized loss on interest rate swaps, net	−12	−5	−11	33	16
Comprehensive income attributable to common stockholders	21	37	13	25	418
Basic (in shares)	55	56	57	56	223
Diluted (in shares)	56	57	57	56	224
Basic (in dollars per share)	0.6	0.75	0.42	−0.14	1.8
Diluted (in dollars per share)	0.6	0.75	0.42	−0.14	1.79

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Land	172	161	158	163	164
Buildings and improvements, less accumulated depreciation of $331,437 and $277,024, respectively	1,617	1,547	1,471	1,717	1,649
Total real estate, net	1,789	1,708	1,629	1,880	1,827
Cash and cash equivalents	32	40	202	13	32
Real estate related notes receivable, net of current expected credit loss reserve of $180 and $0, respectively	17	0	—	—	0
Intangible assets, less accumulated amortization of $112,292 and $122,208, respectively	117	126	135	167	182
Goodwill	18	18	18	22	23
Right-of-use assets - operating leases	35	36	36	37	24
Right-of-use assets - finance lease	2	0	—	—	2
Other assets	85	80	80	100	66
Total assets	2,095	2,007	2,100	2,220	2,178
Credit facility, net of deferred financing costs of $1,878 and $3,079, respectively	674	522	523	581	497
Accounts payable and other liabilities	42	33	30	31	40
Intangible liabilities, less accumulated amortization of $8,939 and $8,761, respectively	6	7	10	12	13
Operating lease liabilities	41	41	41	42	26
Finance lease liabilities	77,000	0	—	—	3
Total liabilities	763	604	605	665	576
Preferred stock, $0.01 par value per share, 100,000,000 shares authorized; none issued and outstanding	0	0	0	0	0
Common stock, $0.01 par value per share, 510,000,000 shares authorized; 61,939,043 and 61,779,631 shares issued, respectively; 54,876,558 and 55,075,006 shares outstanding, respectively	549,000	551,000	570,000	2	2
Additional paid-in capital	1,995	1,999	2,044	2,024	2,004
Distributions in excess of accumulated earnings	−663	−607	−567	−499	−401
Accumulated other comprehensive (loss) income	−1	11	17	28	−5
Total stockholders equity	1,331	1,403	1,494	1,555	1,601
Total liabilities and stockholders equity	2,095	2,007	2,100	2,220	2,178

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	77	75	74	77	82
Amortization of deferred financing costs	3	2	2	2	3
Amortization of above- and below-market leases, net	−529,000	1	733,000	484,000	−1
Amortization of fees on real estate related notes receivable	−94,000	0	0	—	—
Other amortization expenses	733,000	735,000	794,000	2	3
Loss on extinguishment of debt	233,000	228,000	0	3	29
Straight-line rent adjustments, net of write-offs	−9	−6	−2	−7	−16
Stock-based compensation	5	6	6	4	2
Accounts payable and other liabilities	1	12	26,000	−170,000	−5
Other assets	−1	−2	−946,000	909,000	4
Net cash provided by operating activities	119	133	129	122	137
Investments in real estate	−149	−164	−70	−157	−71
Net proceeds from real estate dispositions	0	18	270	23	1,339
Capital expenditures and other costs	−8	−3	−3	−8	−25
Net payments of deposits for investments in real estate	−150,000	−350,000	0	0	−120,000
Fundings of real estate related notes receivable	−18	0	0	—	—
Fees received on real estate related notes receivable	351,000	0	0	—	—
Net cash (used in) provided by investing activities	−174	−150	197	−143	1,227
Proceeds from credit facility	164	270	50	845	15
Payments on credit facility	−13	−270	−108	−762	−453
Payments of deferred financing costs	−6	−3	−193,000	−7	−444,000
Repurchases of common stock	−9	−61	−12	−9	−10
Offering costs on issuance of common stock	0	−61,000	−47,000	−192,000	−2
Distributions to common stockholders	−89	−81	−67	−65	−466
Net cash provided by (used in) financing activities	48	−146	−137	1	−1,399
Net change in cash, cash equivalents and restricted cash	−8	−162	189	−20	−35
Interest paid, net of interest capitalized of $8, $0 and $0, respectively	29	18	22	17	39
Change in accrued distributions related to common stock and performance-based deferred stock unit awards	31,000	−8	630,000	—	—
Change in accrued capital expenditures and other costs	4	507,000	−1	−4	—
Change in accrued acquisition costs related to investments in real estate	3,000	0	0	—	—
Right-of-use assets obtained in exchange for new operating lease liabilities	0	814,000	0	15	625,000
Right-of-use assets obtained in exchange for new finance lease liabilities	74,000	0	0	—	0

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro